Ormosianines A–P, Structurally Diverse Quinolizidine Alkaloids with AChE Inhibitory Effects from Ormosia yunnanensis
Qiong Jin,Xu-Jie Qin,Wen-Jie Sun,Xiao Ding,Yun Zhao,Chang-Bin Wang,Xing-Yu Tao,Xiao-Dong Luo
DOI: https://doi.org/10.1021/acs.jnatprod.3c00493
IF: 5.1
2023-08-17
Journal of Natural Products
Abstract:Sixteen new quinolizidine alkaloids (QAs), named ormosianines A-P (<b>1</b>-<b>16</b>), and 18 known congeners (<b>17</b>-<b>34</b>) were isolated from the stems and leaves of <i>Ormosia yunnanensis</i>. The structures were elucidated based on spectroscopic analyses and electron circular dichroism (ECD) calculations. Structurally, ormosianines A (<b>1</b>) and B (<b>2</b>) are the first examples of cytisine and <i>Ormosia-</i>type alkaloids with the cleavage of the piperidine ring. Results of the acetylcholinesterase (AChE) inhibitory assay revealed that the pentacycline <i>Ormosia-</i>type QAs, including <b>1</b>, <b>16</b>, <b>24</b>, and <b>27</b>-<b>29</b>, are good AChE inhibitors. Ormosianine A (<b>1</b>) exhibited more potent AChE inhibitory activity with an IC<sub>50</sub> value of 1.55 μM. Molecular docking revealed that <b>1</b> might bind to the protein 1DX4, forming two hydrogen bonds with residues SER-238 and HIS-480.
plant sciences,chemistry, medicinal,pharmacology & pharmacy